Advanced Rheumatology Course



Start Date:


End Date:




Max Credits:


Credit Type:


Program Information

The Advanced Rheumatology Course is a comprehensive, innovative online course designed to expand the knowledge and practical skills of providers in rheumatology practice, academic training, and primary care.


AKA: NP/PA Post-Graduate Program


Created specifically for a rheumatology fellows-in-training, primary care providers, nurse practitioners, physician assistants, primary care physicians/internists, residents or providers new to rheumatology. 


Health Professional Online Grant (HPOEG)

The award is up to $1,500 of the registration cost. February 1, 2018 is the next application due date. See details >


Registrants have 12 months from registration date to access and complete modules; after that, access will cease. 


Learning Objectives

At the completion of this course the participant should be able to:

  • Assess, manage, and evaluate patients with rheumatic diseases
  • Describe the scope of practice of the nurse practitioner and physician assistant in the management of rheumatic diseases
  • Describe the impact of rheumatic diseases on individuals and society

Registration & Fees

ARHP members receive a discounted rate. See membership types and join

Note: Registration fees have decreased by 25%.

Registrants have 12 months from date of registration to complete all modules purchased before access ceases.


Modules Included




1-6 & 17-19












Individual Modules




$75 each

$112 each


Group Registration

Group Registration is available for three or more registrants at the same time. Fax the PDF registration form to 404-633-1870.


Modules Included

Member / Non-Member


1-6 & 17-19

$525 each



$675 each



$825 each


To Participate

After registration you will be able to access the following:

  1. Learning objectives
  2. Pre-assignment challenge questions
  3. Audio presentation
  4. Powerpoint slides
  5. Clinical pearls
  6. Post-test assessment*
  7. Activity evaluation

*NOTE: CME credits are not offered at this time but you can email us to receive a certificate of completion.

Core Modules (1 -6)

M1 - Musculoskeletal Structure and Function and Inflammation and Immunity

Learning objectives

Author: Daniel F. Battafarano, DO, FACP, FACR
Chief, Rheumatology Service Adjunct Associate Professor of Medicine Uniformed Services University of Health Sciences Brooke Army Medical Center, San Antonio, TX

M2 - Rheumatic Disease Classification and Framework for Clinical Decision Making 

Learning objectives

Author: Kate T. Queen, MD
Member, Mountain Medical Associates Director, Haywood Regional Medical Center, Osteoporosis Center, Certified Clinical Densitometric, Mountain Medical Associates, Clyde, NC

M3 - Laboratory Evaluation

Learning objectives

Author: Mark H. Wener, MD - Professor and Director of the Immunology sectionision, Department of Laboratory Medicine, University of Washington, Seattle, WA

M4- Imaging of Arthritis: Approach to the Diagnosis of Inflammatory Disease-Revised 2013

Learning objectives

Author: Patrick Astourian, MPAS, PA-C - Grossmont Orthopaedic Medical Group, La Mesa, CA

M5 - Documentation, Coding and Practice Issues-Revised 2011

Learning objectives

Author: Karen L. Kerr, MSN, NP, CPNP, PNP-BC - Rheumatology Nurse Practitioner, Children’s Hospital of Michigan, Detroit, MI 

M6 - Therapeutic Interventions and Resources-Revised 2014

Learning objectives

Author: Donna K. Everix, MPA, PT - Manager Physician Experience / EHR Liaison, Mills-Peninsula Health Services, Burlingame, CA

Adult Modules (7 - 16)

M7 - Osteoarthritis-Revised 2014

Learning objectives

Author: Anne-Marie Malfait, MD PhD - Associate Professor of Medicine (sectionision of Rheumatology) and Biochemistry, Rush University Medical Center, Chicago IL

M8 - Rheumatoid Arthritis and Seronegative Inflammatory Arthropathies-Revised 2013

Learning objectives

Author: Gregory C. Gardner, MD, FACP - Gilliland-Henderson Professor of Medicine, Fellowship Program Director, sectionision of Rheumatology, University of Washington, Seattle, WA

M9 – Systemic Lupus Erythematosus-Revised 2015

Learning objectives

Author: Sima Terebelo, MD, MPH - SUNY Downstate Medical Center, Brooklyn, NY

M 10 - Scleroderma, Myositis and Sjögrens Syndrome

Learning objectives

Author: Chester V. Oddis, MD - Professor of Medicine, sectionision of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA

Author: Meghavi S. (Mona) Kosboth, DO - Clinical Fellow in Rheumatology, University of Florida, Gainesville, FL

Author: Carol Stewart, MS, DDS, MS - Associate Professor, Oral Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, FL

M 11 - Vasculitis, Arteritis and PMR

Learning objectives

Author: Carol Langford, MD, MHS - Director of the Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH

Author: Curry L. Koening, MD, MS - sectionision of Rheumatology, University of Utah, Salt Lake City, UT

Author: Eamonn S. Molloy, MD, MRCPI - Cleveland Clinic Foundation, Cleveland, OH

M 12 - Crystal-induced Arthropathies-Revised 2012

Learning objectives

Author: Joan C. McTigue, MS, PA-C - Associate Editor, University of Florida, Gainesville, FL

M 13 - Pain Syndromes-Revised 2013

Learning objectives

Author: Afton L. Hassett, PsyD - Associate Research Scientist, Department of Anesthesiology, sectionision of Pain Medicine, University of Michigan Medical School, Ann Arbor, MI

Author: Daniel J. Clauw, MD - Professor of Anesthesiology Medicine, Rheumatology and Psychiatry, University of Michigan Medical School, Ann Arbor, MI

M 14 - Spondylarthropathies-Revised 2012

Learning objectives

Author: Atul A. Deodhar, MD, MRCP - Professor of Medicine and Medical Director of Rheumatology Clinics, Oregon Health and Science University, Portland, OR

M 15 - Infectious Processes

Learning objectives

Author: Stanley J. Naides, MD - Medical Director, Immunology Research and Development, Quest Diagnostics Nichols Institute, San Juan, Capistrano, CA

M 16 - Metabolic Bone Disorders-Revised 2011

View the Learning objectives

Author: Michael Maricic, MD - Catalina Pointe Arthritis and Rheumatology, PC, Tucson, Arizona

Pediatric Modules (17 - 19)

M 17 - Chronic Arthropathies of Childhood-Revised 2011

Learning objectives

Author: Betsy Roth-Wojcicki, RN, MS, CPNP - Pediatric Nurse Practitioner/ Clinical Nurse Specialist, Pediatric Rheumatology, Medical College of Wisconsin / Children's Hospital of Wisconsin, Milwaukee, WI

M 18 - Pediatric Connective Tissue Diseases (CTD): Systemic Lupus, Juvenile Dermatomyositis, and Scleroderma-Revised 2013

Learning objectives

Author: Murray H. Passo, MD - Professor of Pediatrics, Medical University of South Carolina, Charleston, SC

M 19 - Pediatric Non-inflammatory Musculoskeletal Pain-Revised 2014

learning objectives

Author: Karla Jones, RN, MS, CPNP CNP - Nationwide Children’s Hospital, Columbus, OH

Author: Sharon Wrona, MS, RN-BC, PNP, PMHS CNP - Nationwide Children’s Hospital, Columbus, OH

Faculty & Disclosures

Scientific Editor
Debra Bancroft Rizzo, MSN, FNP-BC
University of Michigan Health Systems, Dept. of Internal Medicine, Division of Rheumatology, Ann Arbor, MI

Conflict of Interest / Disclosure Statements

Ms. Rizzo is a nurse practitioner in private practice working with nine rheumatologists.

As an educational provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) it is the ACR's policy to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. Faculty participating in an ACR-sponsored activity must disclose to the editorial team and audience any financial or other relationship(s) including, but not limited to:

  1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
  2. Research grants
  3. Employment (full or part-time)
  4. Ownership or partnership
  5. Consulting fees or other remuneration (payment)
  6. Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
  7. Receipt of royalties
  8. Speakers' bureau
  9. Other

Faculty disclosures listed apply in numeric format according to the list above. In accordance with ACR policy an individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for the development, management, presentation or evaluation of the CME activity.

Scientific and Managing Editors

  • Debra Bancroft Rizzo, MSN, FNP-BC - nothing to disclose
  • Anneke Smith - nothing to disclose

2011 - 2015 Authors

  • Patrick Astourian, MPAS, PA-BC - Sono Site Inc., 5
  • Daniel J. Clauw, MD - nothing to disclose
  • Atul A. Deodhar, MD, MRCP - Amgen, Abbott, Genentech, Janssen Pharmaceuticals 2; Janssen Pharmaceuticals 5; Genentech 8
  • Donna K. Everix, MPA, BS, PT - nothing to disclose
  • Gregory C. Gardner, MD - nothing to disclose
  • Afton Hassett, PsyD - Bristol-Myers Squibb, Pfizer, 2, 5
  • Karla B. Jones, RN, MS, CPNP - nothing to disclose
  • Karen L. Kerr, MSN, NP, CPNP, PNP-BC- nothing to disclose
  • Joan C. McTigue, MS, PA-C - nothing to disclose
  • Anne-Marie Malfait, MD, PhD - nothing to disclose
  • Michael J. Maricic, MD - Merck & Co., Novartis, Lilly, Proctor & Gamble Co., Amgen, Genentech, 2, 5, 8
  • Emily M. Myers - nothing to disclose
  • Vivek Nagaraja, MD – nothing to disclose
  • Murray H. Passo, MD - Pfizer, Site PI for Clinical Trials Juvenile Fibromyalgia, 2, DSMB, Pfizer, Investigational Drug, Celecoxib Pediatric Expert Panel, 5
  • Christine A. Stamatos, DNP, ANP-C – nothing to disclose
  • Sima Terebelo, MD, MPH - nothing to disclose
  • Mark H. Wener, MD – nothing to disclose
  • Elizabeth (Betsy) L. Roth-Wojcicki, RN, MS, CPNP- nothing to disclose
  • Sharon Wrona, MS, RN, CPNP - nothing to disclose

2011-2015 Reviewers

  • Roy D. Altman, MD - nothing to disclose
  • Catherine L. Backman, PhD, OT(C) - Western University 9, CHIR 2
  • Chad L. Deal, MD - Theralogix 1, Novartis, Lilly 2, Lilly, Amgen 2, Lilly, Amgen, Novartis, Werner-Chilcott, GSK 8
  • Martha Curry, MS, RN, CPNP - nothing to disclose
  • Laurie A. Hughell, PA-C – Des Moines University 8
  • Diane L. Kamen, MD - nothing to disclose
  • Muhammad Asim Khan, MD, MACP, FRCP - Abbott, Amgen and Pfizer 8.
  • Carol B. Lindsley, MD - University of Kansas Medical Center, Elsevier, 7
  • April L. Marquardt, MD – University of Michigan 2
  • Janet L. Poole, PhD, OTR - nothing to disclose
  • Rick S. Pope, MPAS, PA-C - Takeda 4, Amgen, Takeda, UCB Pharma 8
  • Mark A. Schrager, MD - Rheumatic Disease Center 5, University of Wisconsin School of Medicine 8 and Bread of Healing Clinic 6
  • H. Ralph Schumacher Jr., MD - Pfizer, Takeda, Wyeth 2; Ipsen, Novartis, Pfizer, Regeneron, Savient, Takeda, Xoma 5.
  • Barbara A. Slusher, PA-C, MSW - nothing to disclose
  • Benjamin J. Smith, PA-C - Abbott 5
  • Rachel M. Sullivan, DNP, RN, CPNP - nothing to disclose
  • Susan L. Williams-Judge, MN, CNS, APRN – JUNO 1

CME Information

As of December 31, 2016 CME credits are no longer issued for this course. Registrants will be able to access the modules for educational purposes for up to 12 months from registration date; after that, access to the modules will cease.

ARHP has started revisions to the 19 modules and once completed the three tracks and individual modules will offer CME credits.